This inventor holds 1 USPTO granted patent. Top assignees: Chemo-Sero-Therapeutic Research Institute, Kumamoto University, Tokyo Metropolitan Institute of Medical Science. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 151 
1 out of 98 
1 out of 56 Years Active: 2013
**Title: Masaaki Sato: Innovator in Hepatitis C Virus Inhibition**
Introduction
Masaaki Sato, based in Kumamoto, Japan, is a notable inventor recognized for his innovations in the field of medical science. With a focus on developing treatments for viral infections, he has made significant contributions to the understanding and potential therapeutic approaches for hepatitis C virus (HCV).
Latest Patents
Masaaki Sato holds a patent for hepatitis C virus inhibitors, which aims to provide effective ways to inhibit viral replication in hepatitis C virus-infected cells. His innovation specifically targets BGT-1 and AKR1C1, essential components in the replication process of the virus. The inhibitors developed through this patent show promise in treating hepatitis C by selectively damaging virus-infected cells, lending hope to those affected by this global health issue.
Career Highlights
Throughout his career, Masaaki Sato has collaborated with prominent institutions, contributing to both research and practical applications of his innovations. He has worked at the Juridical Foundation the Chemo-Sero-Therapeutic Research Institute and the Tokyo Metropolitan Institute of Medical Science, where he has put his expertise to good use in advancing medical research and treatment methodologies.
Collaborations
Sato has partnered with esteemed colleagues, including Kyoko Kohara and Michinori Kohara, fostering an environment of collaborative research that has propelled advancements in the field. These partnerships have not only enhanced Sato's work but have also contributed to the broader scientific community's effort to combat infectious diseases.
Conclusion
Masaaki Sato's dedication to medical innovation is evident through his patent for hepatitis C virus inhibitors and his strategic collaborations within the research community. His contributions stand as a testament to the impact that targeted inventions can have on public health, particularly in the battle against viral infections like hepatitis C. Sato's ongoing work continues to inspire future inventions and innovations in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile